Exclusive Matthew Herper, Adam Feuerstein and Jason Mast Biogen’s new CEO, clear-eyed about company’s challenges, prepares to take the reins
A STAT Investigation Jason Mast Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
Exclusive Rachel Cohrs Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
Exclusive Mario Aguilar Large insurer’s decision to cover some prescription digital therapies may be a milestone for app makers
Exclusive Megan Molteni Researchers revive abandoned technique in effort to make artificial human eggs in a test tube
Exclusive Megan Molteni New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal
Exclusive Rachel Cohrs The Catholic hospital system Ascension is running a Wall Street-style private equity fund
Exclusive Jason Mast Day One says drug shrinks tumors in common pediatric brain cancer, setting up potential approval
Exclusive Megan Molteni Eric Lander’s next act: leading a nonprofit set on solving thorny scientific challenges
Exclusive Theresa Gaffney Backed by a longtime mental health leader, a new startup aims to build support for serious mental illness
Exclusive Katie Palmer Thirty Madison, looking to stand out in a crowded telehealth market, quietly plans expansion into sleep care
Exclusive Matthew Herper, Adam Feuerstein and Damian Garde Biogen CEO search focuses on scientists, with former J&J exec as a leading candidate
Exclusive Mario Aguilar Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help
Exclusive Rachel Cohrs White House pitches drug pricing reforms as a way to extend cancer patients’ lives
Exclusive Allison DeAngelis Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments
Exclusive Ed Silverman Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy
Exclusive Matthew Herper and Lev Facher White House to launch effort to develop next generation of Covid vaccines
Exclusive Lev Facher In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
Exclusive Ed Silverman A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
Exclusive Rachel Cohrs Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
Exclusive Helen Branswell Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread